AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2020
Nov 27, 2020
35134_dirs_2020-11-27_bbe13d66-1739-42a5-959b-20f0ba450432.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2020-11-24
Reporting Person: Finizio Robert G (Director, CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-24 | Restricted Stock Unit | $0 | A | 1 | Acquired | Common Stock (1) | Direct |
Footnotes
F1: The restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSU will vest on November 24, 2022.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16